GPR45 抗体 (3rd Cytoplasmic Domain)
Quick Overview for GPR45 抗体 (3rd Cytoplasmic Domain) (ABIN1735105)
抗原
See all GPR45 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- 3rd Cytoplasmic Domain
- 
                                            特异性
- Reacts with human GPR45
- 
                                            交叉反应 (详细)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
- 
                                            纯化方法
- Antigen affinity purified
- 
                                            免疫原
- Synthetic 16 amino acid peptide from 3rd cytoplasmic domain of human GPR45. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Marmoset (100%), Elephant (100%), Horse (100%), Mouse (94%)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Working dilution: ICC, IHC-P (42 μg/mL 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- PBS, Sodium azide 0.1 %
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C/-80 °C
- 
                                            储存方法
- Long term: -70°C, Short term: +4°C
 
- 
                                            
- 
    - GPR45 (G Protein-Coupled Receptor 45 (GPR45))
- 
                                            别名
- GPR45
- 
                                            UniProt
- Q9Y5Y3
 抗原
- 
                    
 
                                     
                                     
                                    